We waited a long time for the arrival of the Yamaha Ténéré 700, but in it’s first two day test in Spain it lived up to expectations, and continued to do so when we took it around the MCN250 ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.